Success Stories: EB1-A Approved Only 11 Days After We filed the case for an Indian Origin Researching the Field of Neuroscience, Premium Processing Requested

 

Client’s Testimonial:

“Thank you for all your help during the process. I am happy that all the hard work done towards I-140 finally paid off.”


On January 7th, 2022, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Neuroscience (Approval Notice).


General Field: Neuroscience

Position at the Time of Case Filing: Postdoctoral Fellow

Country of Origin: India

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: January 7th, 2022

Processing Time: 11 days (Premium Processing Requested)


Case Summary:

The Alien of Extraordinary Ability (EB1A) visa is for a noncitizen of extraordinary ability, for which the applicant must establish his or her extraordinary ability in their chosen fields through sustained national or international acclaim. Therefore, when our client from India, a postdoctoral fellow approached North America Immigration Law Group for his EB1-A application filing, we made sure of going through his submitted credentials thoroughly to put relevant information in his EB1A petition packet, proving his extraordinary ability in the chosen area of expertise.

We helped our client in the preparation of his EB1A petition packet by noting his impressive background, strong record of past achievements, recognition of expertise by journals seeking his services to review manuscripts, and unique knowledge relevant to his current and future work, sustained international acclaim, and his achievements recognized in the field through implementation by others and extensive citation of his work. Some of the followings are:

  • He acquired his Ph.D. degree from India’s well-known University, and he is considered a highly qualified advanced degree scientist with extensive experience in neuropharmacology, toxicology, gene characterization, and drug delivery.
  • His research focuses on exploring the link between cancer genes and neurodegeneration, addressing some of our nations and the world’s most pressing issues, including the mechanisms of neurodegenerative conditions, and targets for novel therapies.
  • His research has been published in some of the top publication venues in his field resulting in 18 peer-reviewed scientific articles and 3 book chapters.
  • Due to his research’s great applicability in the field of neuroscience, his work has been cited 374 times in other peer-reviewed journal articles, placing him in the 1% loftiest cited authors publishing on topics in cell biology, chemistry, and toxicology over the past 7 years according to Microsoft Academic. A number of his publications have been cited by other national and international researchers at a much higher rate than those of other researchers in the field.
  • Another way he has contributed to the field is through his record of peer review. He conducted 65 peer reviews to date and has reviewed dozens of articles. His impressive record is further evidence that he has established himself as a noteworthy researcher and is acknowledged as such within the field.
  • It is evident by the recommendation letters submitted by our client obtained from four internationally recognized experts corroborating that other researchers have also seen the value in his research and its results, which therefore continue to help improve medical science both due to their value and through the work of others. Thus, one of his recommenders stated the below-mentioned:
“In summation, [client] has shown himself to be a skilled and exceptional researcher whose work presents tangible advancements in treating neurological disorders. His work should be supported and encouraged to continue to benefit the people of the United States.”

We are grateful to our client for choosing and trusting our law firm in representing him and his research to the USCIS. Given the prevalence of environmental factors that cause neurological deficits, including Parkinson's disease, we are glad that we were able to establish our client’s invaluable findings for developing therapeutic approaches for these debilitating disorders. We sincerely congratulate him for achieving his EB1A approval in just 11 days, and also, thank him for retaining our services for his and his spouse’s I-485 applications, recently gaining their green cards too. We wish him all the best in his further endeavors.